Risk assessment and drug interruption guidelines for dentoalveolar surgery in patients with osteoporosis receiving anti-resorptive therapy

Medication-related osteonecrosis of the jaw (MRONJ) is a rare and challenging complication of anti-resorptive therapy. This review addresses the critical issue of risk management in patients with osteoporosis who require dentoalveolar surgery while undergoing anti-resorptive therapy. Dental practiti...

Full description

Bibliographic Details

Published in:	Journal of Dental Sciences
Main Authors:	Ling-Ying Wei, Ching-Ming Chiu, Sang-Heng Kok, Hao-Hong Chang, Shih-Jung Cheng, Hung-Ying Lin, Wei-Yih Chiu, Jang-Jaer Lee
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Subjects:	Anti-resorptive agents Dentoalveolar surgery Drug discontinuation Medication-related osteonecrosis of the jaw (MRONJ) Risk assessment
Online Access:	http://www.sciencedirect.com/science/article/pii/S1991790225000340